5 devices · 4 companies · 2013 to 2026

Product code GKZ: Counter, Differential Cell

5 devices under product code GKZ, 2013 to 2026, from 4 companies. Each record carries FDA's decision, the Indications for Use statement verbatim where the public document carries one (3 of 5 here), the regulation, and MAUDE report counts by product code.

Counter, Differential Cell. 21 CFR 864.5220, Class II. MAUDE held 23,449 adverse-event reports against this product code as of 2026-10-29; reports are unverified and the code is shared by every device of this type.

Retrieved from FDA public records.

Companies with more than one device here

Every device, newest decision first

GKZ · 5 devices
DecisionDeviceCompanyPanelFDA
Athelas HomeK243348 · 510(k)Athelas, Inc.Hematologydatabase entry
Athelas HomeK200828 · 510(k)Athelas Inc.Hematologydatabase entry
Sight OLOK190898 · 510(k)Sight Diagnostics Ltd.Hematologydatabase entry
Athelas OneK181288 · 510(k)Athelas Inc.Hematologydatabase entry
UNICEL DXH 800 COULTER CELLULAR ANALYSIS SYSTEMK120771 · 510(k)BECKMAN COULTER, INC.Hematologydatabase entry

Every product code in the record, the whole record of FDA AI-enabled medical devices, or what Apodicta does on a medical record.

Show me on one of my files →

Every device here is authorized for a stated use. See a record read against what it must prove, on your own file.

Show me on my files